Mankind Pharma Limited

Offer PeriodApr 25, 2023 – Apr 27, 2023

Apr 25, 2023 – Apr 27, 2023

MainBoardListed

Listed Price:

₹1,300.00

(+20.37%)

Price Band₹1026 - ₹1080

Lot Size13 Shares

Allotment DateMay 04, 2023

Listing DateMay 09, 2023

Subscription15.32 Times

Issue Size₹4326.36 Cr

Check Allotment

Share IPO Trend

IPO Details

Subscription

Lot Distribution

Reservation

Company Fin.

₹180
(16.67%)

Premium (ELP)

Mankind Pharma Limited's achieved publicly listed status following its IPO debut on May 09, 2023 at the NSE, BSE platform. The offering successfully mobilized 4,00,58,844 Shares, with TBD allocated to corporate growth initiatives and ₹4326.36 Cr providing liquidity to existing shareholders.

Investment participation occurred within the established price band of ₹1,026 to ₹1,080, starting from minimum lots of 13 shares. The subscription window from Apr 25, 2023 through Apr 27, 2023 enabled investor participation across market segments.

Share allocation was completed on May 04, 2023, determining ownership distribution among successful applicants. The listing represents a milestone achievement, transitioning the company to regulated public market status with associated responsibilities and opportunities.

Mankind Pharma IPO Details

IPO Date

Apr 25, 2023 to Apr 27, 2023

Allotment Date

May 04, 2023

List Date

May 09, 2023

Lot Size

13 share

Issue Price

₹1026 - ₹1080

Issue Size

4,00,58,844 (aggregating up to 4326.36 Cr)

Fresh Issue

Offer For Sale

(aggregating up to 4326.36 Cr)

Listing At

NSE, BSE

Share Holding Pre-Issue

40,05,88,440

Share Holding Post-Issue

40,05,88,440

Market Marker Portion

First time applying for an IPO? Read our guide on How to Apply for an IPO & Bidding Timings.

Lot(s) Distribution

Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.

Category	Lot(s)	Qty	Amount

Category	Lot(s)	Qty	Amount
Retail (Min)	1	13	14,040
sHNI	15	195	2,10,600
bHNI	72	936	10,10,880

IPO Reservation

Shares4,00,58,844

QIB

50.00%(2,00,29,421)

NII (HNI)

15.00%(60,08,827)

RETAIL

35.00%(1,40,20,596)

Total

100.00%(4,00,58,844)

Mankind Pharma IPO Key Performance Indicators

Learn About IPO KPIs →

KPI	Values

KPI	Values
33.20	33.20
ROE	27.60
ROCE	26.10
27.70	27.70
33.20	32.5
0	0

Want to understand how to evaluate these metrics? Read our guide on IPO Key Performance Indicators (KPIs).

Company Financials ( In Crores)

Period Ended	Mar 2020	Mar 2021	Dec 2021	Mar 2022	Dec 2022

Period Ended	Mar 2020	Mar 2021	Dec 2021	Mar 2022	Dec 2022
Assets	5,073.29	6,372.63	8,043.88	9,147.74	9,273.75
Revenue	5,975.65	6,385.38	6,218.29	7,977.58	6,777.82
Net Worth	3,485.31	4,722.00	5,965.46	6,155.23	7,145.89
Total borrowing	126.92	234.53	268.70	868.03	167.93
Profit after tax	1,056.15	1,293.03	1,260.24	1,452.96	1,015.98
Reserves and Surpluses	3,436.34	4,674.39	5,916.86	6,106.06	7,094.12

Mankind Pharma IPO About Company

Incorporated in 1991, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products across a wide range of acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients, and respiratory. The company offers over 36 brands such as Manforce, Moxikind-CV, Amlokind-AT, Prega News, and Gudcef, supported by one of the largest distribution networks of medical representatives in India, with over 80% of doctors prescribing its formulations. Ranked 4th in domestic sales in FY2022, Mankind Pharma has received numerous awards, including The Best of Bharat Awards 2022, National Awards for Manufacturing Competitiveness Silver Medal 2021, and recognition for Best Design in Healthcare and performance management excellence.

Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."

✅Mankind Pharma IPO Strength Factors

⚠️Mankind Pharma IPO Risk Factors

🏦Mankind Pharma IPO Lead Manager(s)

Kotak Mahindra Capital CompanyAxis Capital LimitedIIFL Capital Services LimitedJefferies India Private LimitedJ.P. Morgan India Private Limited

👤Mankind Pharma IPO Promoter(s)

Ramesh Juneja
Rajeev Juneja
Sheetal Arora
Ramesh Juneja Family Trust
Rajeev Juneja Family Trust
Prem Sheetal Family Trust

🏢Mankind Pharma IPO Company Details

Mankind Pharma Limited

Email:investors@mankindpharma.com

Phone:+91 11 4684 6700

Website:https://www.mankindpharma.com/

address:208, Okhla Industrial Estate Phase-III, New Delhi 110020

📋Mankind Pharma IPO Registrar

KFin Technologies Limited

Name:KFin Technologies Limited

Phone:04067162222

Email:mankind.ipo@kfintech.com

Website:https://karisma.kfintech.com/

❓Mankind Pharma IPO FAQs

Mankind Pharma IPO is a main-board IPO of 0 equity shares of the face value of ₹1 Per Share aggregating up to ₹4326.36 crore shares. The issue is priced at ₹1026 - ₹1080 per share. The minimum order quantity is .The IPO opens on Apr 25, 2023, and closes on Apr 27, 2023. Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE, BSE.

Zerodha customers can apply online in Mankind Pharma IPO using UPI as a payment gateway. Zerodha customers can apply in Mankind Pharma IPO by login into Zerodha Console (back office) and submitting an IPO application form. Steps to apply in Mankind Pharma IPO through Zerodha (1) Visit the Zerodha website and login to Console. (2) Go to Portfolio and click the IPOs link. (3) Go to the 'Mankind Pharma IPO' row and click the 'Bid' button. (4) Enter your UPI ID, Quantity, and Price. (5) Submit IPO application form. (6) Visit the UPI App (net banking or BHIM) to approve the mandate. Visit Zerodha IPO Application Process Review for more detail.

The Mankind Pharma IPO opens on Apr 25, 2023 and closes on Apr 27, 2023.

You can apply in Mankind Pharma IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.

The finalization of Basis of Allotment for Mankind Pharma IPO will be done on May 04, 2023, and the allotted shares will be credited to your demat account by May 04, 2023

Mankind Pharma IPO's listing date is May 09, 2023.

Mankind Pharma Limited

IPO Details

Subscription

Lot Distribution

Reservation

Company Fin.

₹180(16.67%)

Premium (ELP)

₹180
(16.67%)